Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / Scaling Science My Precision Medicine Accessibility Mission
Oncology Profession Career Pathways Voices in the Community Molecular Pathology

Scaling Science: My Precision Medicine Accessibility Mission

Sitting Down With… Luca Quagliata, Vice President and Global Head of Medical Affairs at Thermo Fisher Scientific

By Helen Bristow 02/03/2026 Interview 4 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders

Share

Clinical Scorecard: Scaling Science: My Precision Medicine Accessibility Mission

At a Glance

CategoryDetail
ConditionPrecision Medicine Accessibility
Key MechanismsCollaboration between academia and industry, patient-centric approaches, and technological innovation.
Target PopulationGlobal oncology community and patients requiring precision medicine.
Care SettingIndustry and academic partnerships.

Key Highlights

  • Leadership combines scientific expertise with business capability.
  • Importance of recognizing team achievements while taking responsibility for failures.
  • Continuous learning is essential for staying current in the field.
  • Social responsibility is a key factor in decision-making in industry.
  • Collaboration is crucial for achieving accessible precision medicine.

Guideline-Based Recommendations

Diagnosis

  • Adopt a patient-centric view in all practices.

Management

  • Encourage partnerships between academia, industry, and medical societies.

Monitoring & Follow-up

  • Continuously assess the impact of solutions on patient accessibility.

Risks

  • Misconceptions about industry motivations can hinder collaboration.

Patient & Prescribing Data

Patients globally who could benefit from precision medicine.

Current solutions are impactful but only reach a fraction of potential beneficiaries.

Clinical Best Practices

  • Foster an environment that enables team decision-making.
  • Maintain a broad perspective by learning outside one's field.
  • Prioritize social responsibility alongside business objectives.

References

  • Thermo Fisher Scientific

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Real-Life Forensic Pathology Is Not CSI
Professional Development
Real-Life Forensic Pathology Is Not CSI

January 30, 2024

5 min read

Sitting Down With… Ken Obenson, Forensic Pathologist at The Saint John Regional Hospital, New Brunswick, Canada

The Transformative Power of Patient Advocacy
Professional Development
The Transformative Power of Patient Advocacy

January 24, 2024

3 min read

Michele Mitchell shares her personal journey into patient advocacy

Navigating Digital Scholarship and Professional Growth
Professional Development
Navigating Digital Scholarship and Professional Growth

January 16, 2024

5 min read

How can new-in-practice pathologists leverage the power of social media to enhance traditional academic work?

Byte the Bias
Professional Development
Byte the Bias

January 11, 2024

1 min read

How does artificial intelligence view a pathologist?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.